ASPC 2018 Congress on CVD Prevention
SESSION 3 - Cardiometabolic
ASPC 2018 Congress on CVD Prevention
Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, a Seminal Transition in DM Management
FEATURING
Mikhail Kosiborod
- 973 views
- August 10, 2018
- 3
ASPC 2018 Congress on CVD Prevention
Comprehensive Approach to Lowering CVD Risk in Diabetics
FEATURING
Yehuda Handelsman
- 777 views
- August 10, 2018
- 6
ASPC 2018 Congress on CVD Prevention
Differentiating Antiplatelet Agents
FEATURING
Peter Toth
- 624 views
- August 10, 2018
- 4
ASPC 2018 Congress on CVD Prevention
SESSION 3 - Cardiometabolic Discussion
- 23 views
- August 10, 2018